ACTIVE

PHARMACAM

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

16,6 k €

-18.8% YoY

Gross margin

162,9 k €

+2.6% YoY

Equity

306,7 k €

+5.7% YoY

What does PHARMACAM do?

PHARMACAM is a Private limited company incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Kraainem.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0817.415.436

Incorporation

29/07/2009

Legal form

Private limited company

Registered office

Avenue Arthur Dezangré 35
1950 Kraainem · FlandreSee on map

Contributed capital

69 850,38 €

Latest accounts

31/12/2024

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010
Income statement
Gross margin	162,9 k €	+2.6%	158,8 k €	+26.1%	125,9 k €	+81.2%	69,5 k €	-46.4%	129,7 k €	-18.1%	158,3 k €	+8.1%	146,5 k €	-15.6%	173,5 k €	-1.2%	175,6 k €	-3.0%	181,2 k €	-2.8%	186,4 k €	-14.9%	219,1 k €	+8.0%	202,8 k €	+16.6%	173,9 k €	-28.1%	241,8 k €
EBITDA	33,9 k €	-2.8%	34,8 k €	+0.0%	34,8 k €	+275%	-19,9 k €	-126%	76,4 k €	-29.8%	108,8 k €	+11.4%	97,6 k €	-22.3%	125,6 k €	-2.0%	128,2 k €	-0.7%	129,1 k €	-9.1%	142 k €	-19.4%	176,2 k €	+10.0%	160,2 k €	+18.0%	135,8 k €	-25.5%	182,3 k €
Operating result	25,3 k €	-4.2%	26,4 k €	+1.2%	26,1 k €	+192%	-28,3 k €	-142%	67,2 k €	-29.7%	95,5 k €	+12.4%	85 k €	-25.4%	114 k €	-2.0%	116,3 k €	-0.0%	116,4 k €	+37.9%	84,4 k €	-12.3%	96,3 k €	+37.0%	70,3 k €	+46.0%	48,1 k €	+33.0%	36,2 k €
Net result	16,6 k €	-18.8%	20,4 k €	-17.6%	24,8 k €	+185%	-29,1 k €	-158%	50,5 k €	-37.0%	80,1 k €	+23.4%	64,9 k €	-18.6%	79,7 k €	-5.6%	84,4 k €	+10.5%	76,4 k €	+50.7%	50,7 k €	-14.0%	58,9 k €	+33.9%	44 k €	+75.4%	25,1 k €	+84.2%	13,6 k €
Balance sheet
Equity	306,7 k €	+5.7%	290,1 k €	+7.6%	269,7 k €	+10.1%	244,9 k €	-60.9%	626,7 k €	-46.0%	1,2 M €	+7.3%	1,1 M €	+6.4%	1 M €	+8.5%	937 k €	+9.9%	852,6 k €	+9.8%	776,2 k €	+7.0%	725,6 k €	+8.8%	666,7 k €	+7.1%	622,7 k €	+4.2%	597,6 k €
Total assets	374,9 k €	-15.5%	443,9 k €	+19.3%	372,2 k €	+15.5%	322,3 k €	-52.4%	677 k €	-43.5%	1,2 M €	+4.8%	1,1 M €	+6.4%	1,1 M €	+6.4%	1 M €	+5.9%	953,1 k €	+6.3%	896,6 k €	+8.3%	827,9 k €	+6.4%	778,1 k €	+4.5%	744,4 k €	+4.7%	710,9 k €
Cash	37,5 k €	-78.6%	175 k €	+10.4%	158,5 k €	+51.6%	104,5 k €	-77.7%	468,4 k €	-39.1%	768,6 k €	+5.7%	727 k €	+9.6%	663,3 k €	+8.8%	609,4 k €	+13.4%	537,6 k €	+2.1%	526,7 k €	-0.8%	530,7 k €	+25.8%	421,9 k €	+37.8%	306,2 k €	+83.4%	167 k €
Debts	68,2 k €	-46.7%	127,8 k €	+48.7%	86 k €	+91.0%	45 k €	-9.0%	49,5 k €	+32.4%	37,4 k €	-39.1%	61,3 k €	+7.3%	57,2 k €	-21.1%	72,4 k €	-27.4%	99,7 k €	-16.7%	119,7 k €	+17.6%	101,8 k €	-8.2%	110,9 k €	-8.8%	121,6 k €	+7.3%	113,3 k €
Other
Workforce	–		1,6 ETP	+6.7%	1,5 ETP	+150%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 5 ended

Active mandates

PHARMALEC

Director · 0678.956.844

Represented by Andreas Ghijselings

Active

Ended mandates

PHARMALEC

Director · since 28 janvier 2021 · 0678.956.844

Represented by Andreas GHIJSELINGS

Ended

Hilde Rachel PIENS

Director

Ended

Hilde Rachel PIENS

Manager · until 28 janvier 2021

Ended

Hilde Rachel PIENS

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
CTO LIMBURG● Active	0450.822.544
Vereniging van mede-eigenaars , Dezangrelaan 35, 1950 Kraainem● Active	0893.576.866

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2025	24/06/2024	31/08/2023	26/08/2022	03/09/2021	14/10/2020
General meeting	31/07/2025	15/06/2024	15/06/2023	15/06/2022	15/06/2021	15/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

15 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	31/07/2025	28/08/2025	Dutch	PDF
Abridged model	31/12/2023	15/06/2024	24/06/2024	Dutch	PDF
Abridged model	31/12/2022	15/06/2023	31/08/2023	Dutch	PDF
Abridged model	31/12/2021	15/06/2022	26/08/2022	Dutch	PDF
Abridged model	31/12/2020	15/06/2021	03/09/2021	Dutch	PDF
Abridged model	31/12/2019	15/06/2020	14/10/2020	Dutch	PDF
Abridged model	31/12/2018	15/06/2019	31/08/2019	Dutch	PDF
Abridged model	31/12/2017	15/06/2018	31/08/2018	Dutch	PDF
Abridged model	31/12/2016	15/06/2017	22/09/2017	Dutch	PDF
Abridged model	31/12/2015	15/06/2016	29/08/2016	Dutch	PDF
Abridged model	31/12/2014	15/06/2015	28/09/2015	Dutch	PDF
Abridged model	31/12/2013	16/06/2014	26/08/2014	Dutch	PDF
Abridged model	31/12/2012	15/06/2013	30/09/2013	Dutch	PDF
Abridged model	31/12/2011	15/06/2012	29/03/2013	Dutch	PDF
Abridged model	31/12/2010	15/06/2011	30/09/2011	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 5 ended

Active mandates

PHARMALEC

Director · 0678.956.844

Represented by Andreas Ghijselings

Active

Ended mandates

PHARMALEC

Director · since 28 janvier 2021 · 0678.956.844

Represented by Andreas GHIJSELINGS

Ended

Hilde Rachel PIENS

Director

Ended

Hilde Rachel PIENS

Manager · until 28 janvier 2021

Ended

Hilde Rachel PIENS

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/02/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/12/2020
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Other10/08/2009
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202416,6 k €↓
2023
Annual accounts 202320,4 k €↓
2022
Annual accounts 202224,8 k €↑
2021
Annual accounts 2021-29,1 k €↓
2020
Annual accounts 202050,5 k €↓
2019
Annual accounts 201980,1 k €↑
2018
Annual accounts 201864,9 k €↓
2017
Annual accounts 201779,7 k €↓
2016
Annual accounts 201684,4 k €↑
2015
Annual accounts 201576,4 k €↑
2014
Annual accounts 201450,7 k €↓
2013
Annual accounts 201358,9 k €↑
2012
Annual accounts 201244 k €↑
2011
Annual accounts 201125,1 k €↑
2010
Annual accounts 201013,6 k €
29/07/2009
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMACAM

Overview

What does PHARMACAM do?

Trend over 15 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline